Graham Capital Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.2K | Sell |
35,475
-89,326
| -72% | -$104K | ﹤0.01% | 1209 |
|
|
2025
Q1 | $198K | Buy |
124,801
+66,855
| +115% | +$106K | ﹤0.01% | 1106 |
|
|
2024
Q4 | $176K | Buy |
57,946
+15,760
| +37% | +$47.8K | ﹤0.01% | 1072 |
|
|
2024
Q3 | $155K | Buy |
42,186
+30,721
| +268% | +$113K | ﹤0.01% | 933 |
|
|
2024
Q2 | $46.9K | Buy |
+11,465
| New | +$46.9K | ﹤0.01% | 959 |
|
|
2023
Q4 | – | Sell |
-10,600
| Closed | -$213K | – | 1373 |
|
|
2023
Q3 | $213K | Buy |
+10,600
| New | +$213K | 0.01% | 828 |
|